surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3
Description
The PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 49 peptides and 14 pathways, identifying your inherited predispositions in GLP1R, GIPR, FTO, and MC4R variants
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3](https://www.researchgate.net/publication/391528797/figure/fig1/AS:11431281428208294@1746663768680/Flow-chart-of-the-SURMOUNT-3-study.jpg)
Is it dangerous to take 20 units every week indefinitely
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-023-02597-w/MediaObjects/41591_2023_2597_Fig2_HTML.png)
A key finding was that the magnitude of semaglutides effects on several drinking outcomes appeared greater than is often seen with existing medications to reduce alcohol cravings, even though semaglutide was only administered at the lowest clinical doses
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3](https://www.nejm.org/cms/asset/67482ba8-0712-42b2-8a78-c184135fcbe8/nejmoa2416394_f1.jpg)
Despite the debated GLP-1R expression in islet alpha-cells, recent studies have provided evidence that GLP-1R agonists may mediate direct effects on alpha-cells via GLP-1R action
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3](https://www.thelancet.com/cms/10.1016/S0140-6736(26)00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
In other words, sometimes you are retaining water for lifestyle choices that are easily resolved or undone, while other times you are retaining water because of diseases that must be treated by medical professionals
Final Overview: What to Take From This Before You Decide That decision belongs to you, after a real conversation with a licensed provider
![surmount 3 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Flow chart of the SURMOUNT-3](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/05/shutterstock_2165071487.jpg)